Free Trial
NASDAQ:ZURA

Zura Bio (ZURA) Stock Price, News & Analysis

Zura Bio logo
$1.46 +0.07 (+4.64%)
As of 02:01 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Zura Bio Stock (NASDAQ:ZURA)

Key Stats

Today's Range
$1.35
$1.49
50-Day Range
$1.00
$1.96
52-Week Range
$0.97
$5.07
Volume
332,396 shs
Average Volume
527,681 shs
Market Capitalization
$100.18 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$14.33
Consensus Rating
Buy

Company Overview

Zura Bio Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
73rd Percentile Overall Score

ZURA MarketRank™: 

Zura Bio scored higher than 73% of companies evaluated by MarketBeat, and ranked 355th out of 934 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Zura Bio has received a consensus rating of Buy. The company's average rating score is 3.13, and is based on 7 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Zura Bio has only been the subject of 1 research reports in the past 90 days.

  • Read more about Zura Bio's stock forecast and price target.
  • Earnings Growth

    Earnings for Zura Bio are expected to decrease in the coming year, from ($0.65) to ($0.78) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Zura Bio is -2.12, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Zura Bio is -2.12, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Zura Bio has a P/B Ratio of 0.65. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Zura Bio's valuation and earnings.
  • Percentage of Shares Shorted

    1.52% of the float of Zura Bio has been sold short.
  • Short Interest Ratio / Days to Cover

    Zura Bio has a short interest ratio ("days to cover") of 0.8, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Zura Bio has recently decreased by 64.92%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Zura Bio does not currently pay a dividend.

  • Dividend Growth

    Zura Bio does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    1.52% of the float of Zura Bio has been sold short.
  • Short Interest Ratio / Days to Cover

    Zura Bio has a short interest ratio ("days to cover") of 0.8, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Zura Bio has recently decreased by 64.92%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Zura Bio has a news sentiment score of 1.11. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.63 average news sentiment score of Medical companies.
  • Search Interest

    9 people have searched for ZURA on MarketBeat in the last 30 days. This is an increase of 200% compared to the previous 30 days.
  • MarketBeat Follows

    2 people have added Zura Bio to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Zura Bio insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    14.23% of the stock of Zura Bio is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    61.14% of the stock of Zura Bio is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Zura Bio's insider trading history.
Receive ZURA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Zura Bio and its competitors with MarketBeat's FREE daily newsletter.

ZURA Stock News Headlines

If you saw this, you'd be scared too
Markets may look strong—but one veteran analyst warns we’re nearing a financial breaking point. After 40+ years of navigating crashes and crises, he says traditional strategies could soon become wealth destroyers. A time-sensitive briefing reveals what to do now.
See More Headlines

ZURA Stock Analysis - Frequently Asked Questions

Zura Bio's stock was trading at $2.50 at the beginning of 2025. Since then, ZURA stock has decreased by 40.6% and is now trading at $1.4850.

Zura Bio Limited (NASDAQ:ZURA) posted its quarterly earnings results on Thursday, May, 8th. The company reported ($0.19) EPS for the quarter, missing the consensus estimate of ($0.17) by $0.02.

Zura Bio's top institutional shareholders include Y Intercept Hong Kong Ltd (0.16%). Insiders that own company stock include Someit Sidhu, Van Amstel Arnout Ploos, Michael Howell, Kiran Nistala and Parvinder Thiara.
View institutional ownership trends
.

Shares of ZURA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Zura Bio investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), Meta Platforms (META), Tesla (TSLA), JPMorgan Chase & Co. (JPM), Netflix (NFLX) and Walt Disney (DIS).

Company Calendar

Last Earnings
5/08/2025
Today
8/01/2025
Next Earnings (Estimated)
8/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:ZURA
CIK
1855644
Web
N/A
Fax
N/A
Employees
3
Year Founded
N/A

Price Target and Rating

High Price Target
$26.00
Low Price Target
$3.00
Potential Upside/Downside
+923.8%
Consensus Rating
Buy
Rating Score (0-4)
3.13
Research Coverage
8 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.70)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$45.39 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-42.84%
Return on Assets
-35.22%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
8.14
Quick Ratio
8.14

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$2.27 per share
Price / Book
0.62

Miscellaneous

Outstanding Shares
68,380,000
Free Float
58,645,000
Market Cap
$95.73 million
Optionable
Optionable
Beta
-0.10
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

This page (NASDAQ:ZURA) was last updated on 8/1/2025 by MarketBeat.com Staff
From Our Partners